Related Experiment Video
Updated: Jun 23, 2026

The Importance of Correct Protein Concentration for Kinetics and Affinity Determination in Structure-function Analysis
Published on: March 17, 2010
Association of cystatin C with adverse outcomes
Magdalena Madero1, Mark J Sarnak
1Division of Nephrology, Instituto Nacional de Cardiología Ignacio Chávez, México City, Mexico.
Insights
Cystatin C effectively identifies mild kidney disease risks for mortality and cardiovascular disease (CVD). This marker shows associations even within normal kidney function ranges, aiding in risk assessment for older adults.
Area of Science:
- Biomarkers in Nephrology
- Cardiovascular Risk Assessment
- Geriatric Medicine
Background:
- Cystatin C is a protein produced by all nucleated cells, influenced by factors beyond kidney function.
- Creatinine is a commonly used marker for estimating glomerular filtration rate (GFR), but its accuracy can be affected by muscle mass.
- Understanding the determinants and clinical utility of cystatin C is crucial for accurate risk stratification.
Purpose of the Study:
- To review recent studies on cystatin C determinants.
- To analyze the relationship between cystatin C and mortality, cardiovascular disease (CVD), and noncardiovascular outcomes.
- To compare the predictive value of cystatin C with creatinine.
Main Methods:
- Review of recent epidemiological and cohort studies.
- Analysis of associations between cystatin C levels and demographic characteristics.
- Correlation of cystatin C with measured glomerular filtration rate (GFR).
Main Results:
- Cystatin C is associated with demographic factors, independent of GFR, though to a lesser extent than creatinine.
- In chronic kidney disease (CKD) patients, cystatin C strongly correlates inversely with GFR, confirming its role as a kidney function measure.
- Cohort studies, especially in older adults, show cystatin C linearly associates with mortality and CVD/non-CVD outcomes, unlike creatinine which is more specific to advanced kidney disease.
Conclusions:
- Cystatin C effectively identifies increased risk of mortality and non-CVD outcomes associated with mild kidney disease.
- Changes in kidney function, as measured by cystatin C even within normal ranges, predict subsequent CVD and all-cause mortality in older adults.
- Future research should explore cystatin C's potential to enhance medical decision-making and improve patient outcomes.
Purpose Of Review:
To discuss recent studies which have evaluated determinants of cystatin C and to focus on the relationship of cystatin C with mortality, cardiovascular disease (CVD), and noncardiovascular outcomes.
Recent Findings:
In the Chronic Kidney Disease Epidemiology Study cystatin C was associated with demographic characteristics independent of measured glomerular filtration rate (GFR), although this was to a smaller extent than creatinine. In patients with established chronic kidney disease (CKD), cystatin C was strongly and inversely correlated with measured GFR, suggesting that although cystatin C may have other determinants, it is primarily a measure of kidney function. Several cohort studies, particularly in older adults, have now demonstrated that cystatin C is linearly associated with mortality, CVD and non-CVD outcomes, whereas creatinine is primarily associated with risk in individuals with more advanced kidney disease. A recent study has also shown that changes in kidney function as ascertained by cystatin C, even within the relatively normal range, are associated with subsequent CVD and all-cause mortality among older adults.
Summary:
Cystatin C appears to capture an association of mild kidney disease with increased risk of mortality, CVD and non-CVD outcomes. Future studies should evaluate whether cystatin C can improve medical decision-making and lead to favorable patient outcomes.
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Urinary Tract Calculi I: Introduction
Caspases
Cystic Fibrosis: Management
Sinus disease and chronic sinusitis...
Acute Pancreatitis II: Pathophysiology
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...